Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Huang-Lian-Jie-Du Decoction (MHLJDD) is a traditional Chinese herbal medicine formula derived from the classical Huang-Lian-Jie-Du Decoction (HLJDD). The original HLJDD consists of four herbs: Rhizoma Coptidis (Huanglian), Radix Scutellariae (Huangqin), Cortex Phellodendri (Huangbo), and Fructus Gardeniae (Zhizi). In the modified version, Fructus Gardeniae has been replaced with Dictamni cortex due to the remarkable liver and kidney toxicities associated with Gardeniae fructus. MHLJDD has demonstrated various therapeutic effects including anti-inflammatory, anti-bacterial, anti-endotoxic, and immunomodulatory activities. It has been studied for its efficacy in treating conditions such as Alzheimer's disease, sepsis, and oral diseases caused by "Shanghuo" (excessive internal heat). Research has shown that MHLJDD may regulate energy metabolism and synaptic plasticity, potentially through NMDA receptor-mediated glutamatergic transmission and adenosine/ATPase/AMPK cascade.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Modified Huang-Lian-Jie-Du Decoction.